Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 10 of 12 descriptions
| No. | 薬物名（臨床試験情報から抽出） | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | BORTEZOMIB (D03150) | 2件: Bortezomib Bortezomib,Bortezomib D-mannitol | 1件: Bortezomib
Bortezomib
(D03150) 💬1. BORTEZOMIB
| 1件: PSMB5 PSMB5 💬1. BORTEZOMIB
| 8件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathway ... | 17件: 11 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 222, 228, 256, 283, 288, 331 💬1. BORTEZOMIB
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 | Bortezomib (Velcade®) (D03150) | 1件: Bortezomib Bortezomib | 1件: Bortezomib
Bortezomib
(D03150) 💬2. Bortezomib (Velcade®)
| 1件: PSMB5 PSMB5 💬2. Bortezomib (Velcade®)
| 8件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathway ... | 1件: 66 66 💬2. Bortezomib (Velcade®)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 | Bortezomib Accord (D03150) | 2件: Bortezomib Bortezomib,Bortezomib D-mannitol | 1件: Bortezomib
Bortezomib
(D03150) 💬3. Bortezomib Accord
| 1件: PSMB5 PSMB5 💬3. Bortezomib Accord
| 8件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathway ... | 1件: 28 28 💬3. Bortezomib Accord
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 4 | Bortezomib D-mannitol (D03150) | 3件: Bortezomib Bortezomib,Bortezomib D-mannitol, Mannitol | 2件: Mannitol
Mannitol
,Bortezomib (D03150) 💬 4. Bortezomib D-mannitol
| 1件: PSMB5 PSMB5 💬4. Bortezomib D-mannitol
| 8件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathway ... | 1件: 28 28 💬4. Bortezomib D-mannitol
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 | Bortezomib Injection (D03150) | 1件: Bortezomib Bortezomib | 1件: Bortezomib
Bortezomib
(D03150) 💬5. Bortezomib Injection
| 1件: PSMB5 PSMB5 💬5. Bortezomib Injection
| 8件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathway ... | 1件: 64 64 💬5. Bortezomib Injection
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 | Bortezomib/dexamethasone (D03150) | 2件: Bortezomib Bortezomib,Dexamethasone | 2件: Dexamethasone
Dexamethasone
,Bortezomib (D03150) 💬 6. Bortezomib/dexamethasone
| 2件: NR3C1 NR3C1,PSMB5 💬 | 9件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-recepto ... | 1件: 283 283 💬6. Bortezomib/dexamethasone
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 | Bortezomib/Dexamethasone (BD), Followed By Autologous STC & Maintenance Bortezomib/Dexamethasone (D03150) Bortezomib/Dexamethasone (BD), Followed By Autologous STC & Maintenance Bortezomib/Dexamethasone (D03 ... | 2件: Bortezomib Bortezomib,Dexamethasone | 2件: Dexamethasone
Dexamethasone
,Bortezomib (D03150) 💬 7. Bortezomib/Dexamethasone (BD), Followed By Autologous STC & Maintenance Bortezomib/Dexamethasone
| 2件: NR3C1 NR3C1,PSMB5 💬 | 9件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-recepto ... | 1件: 28 28 💬7. Bortezomib/Dexamethasone (BD), Followed By Autologous STC & Maintenance Bortezomib/Dexamethasone
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 | Combination of a single dose anti-CD20 antibody and bortezomib (D03150) | 1件: Bortezomib Bortezomib | 1件: Bortezomib
Bortezomib
(D03150) 💬8. Combination of a single dose anti-CD20 antibody and bortezomib
| 1件: PSMB5 PSMB5 💬8. Combination of a single dose anti-CD20 antibody and bortezomib
| 8件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 8件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Parkinson disease, Pathway ... | 1件: 61 61 💬8. Combination of a single dose anti-CD20 antibody and bortezomib
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 9 | Cyclophosphamide, bortezomib, and Dexamethasone (CyBorD) regimen (D03150) | 3件: Bortezomib Bortezomib,Cyclophosphamide, Dexamethasone | 4件: Cyclophosphamide
Cyclophosphamide
,Dexamethasone , Bortezomib (D03150), Cyclophosphamide 💬 9. Cyclophosphamide, bortezomib, and Dexamethasone (CyBorD) regimen
| 2件: NR3C1 NR3C1,PSMB5 💬 | 9件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-recepto ... | 1件: 28 28 💬9. Cyclophosphamide, bortezomib, and Dexamethasone (CyBorD) regimen
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10 | Cyclophosphamide, Bortezomib, dexamethasone (D03150) | 3件: Bortezomib Bortezomib,Cyclophosphamide, Dexamethasone | 4件: Cyclophosphamide
Cyclophosphamide
,Dexamethasone , Bortezomib (D03150), Cyclophosphamide 💬 10. Cyclophosphamide, Bortezomib, dexamethasone
| 2件: NR3C1 NR3C1,PSMB5 💬 | 9件: Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-receptor interaction, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Prion disease, Proteasome, Spinocerebellar ataxia 💬 9件: Alzheimer disease, Amyotrophic lateral sclerosis, Huntington disease, Neuroactive ligand-recepto ... | 1件: 28 28 💬10. Cyclophosphamide, Bortezomib, dexamethasone
|